0.07% -0.015

Organon Co (OGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Organon Co Stock (OGN) Company Profile

Healthcare (1087)

551-430-6000

30 HUDSON STREET, JERSEY CITY

Nächster Verdiensttermin

Neueste SEC-Einreichungen

OGN's Discussions on Twitter

Compare OGN vs LLY, JNJ, ABBV, MRK, NVS

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OGN Organon Co	13.73	3.61B	6.16B	246.00M	708.00M	0.9387
LLY Lilly Eli Co	1,130.76	1.00T	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	269.04	648.55B	97.93B	21.04B	17.80B	8.6278
ABBV Abbvie Inc	248.61	439.62B	62.82B	3.60B	19.98B	2.0274
MRK Merck Co Inc	147.72	366.28B	65.51B	8.93B	14.12B	3.5532
NVS Novartis Ag Adr	138.83	261.73B	54.66B	13.58B	16.05B	7.0171

Organon Co Stock (OGN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-09	Eingeleitet	Barclays	Underweight
2025-10-27	Herabstufung	Piper Sandler	Overweight → Underweight
2025-05-02	Herabstufung	Evercore ISI	Outperform → In-line
2024-09-06	Herabstufung	JP Morgan	Neutral → Underweight
2023-11-03	Herabstufung	Goldman	Buy → Neutral
2023-09-21	Eingeleitet	Barclays	Overweight
2023-03-16	Eingeleitet	Raymond James	Outperform
2022-10-14	Herabstufung	BofA Securities	Neutral → Underperform
2022-09-06	Hochstufung	Piper Sandler	Neutral → Overweight
2022-08-05	Herabstufung	BofA Securities	Buy → Neutral
2022-04-27	Eingeleitet	Goldman	Buy
2022-04-06	Fortgesetzt	Morgan Stanley	Equal-Weight
2021-10-07	Eingeleitet	Piper Sandler	Neutral
2021-09-01	Eingeleitet	BofA Securities	Buy
2021-07-22	Eingeleitet	Citigroup	Buy
2021-06-15	Eingeleitet	JP Morgan	Neutral
2021-06-11	Eingeleitet	Morgan Stanley	Equal-Weight
2021-06-10	Eingeleitet	Evercore ISI	Outperform

Alle ansehen

Organon Co Aktie (OGN) Neueste Nachrichten

Finanzdaten der Organon Co-Aktie (OGN)

Organon Co (OGN)

Organon Co Stock (OGN) Company Profile

Compare OGN vs LLY, JNJ, ABBV, MRK, NVS

Organon Co Stock (OGN) Upgrades & Downgrades

Organon Co Aktie (OGN) Neueste Nachrichten

Sun Pharma gets ratings boost from Moody's, S&P over $11.75-bn Organon bid - Business Standard

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Sun Pharma receives ratings boost over USD 11.75-billion Organon acqui - Daily Pioneer

Sun Pharma Gets Ratings Boost From Moody's, S&P Over $11.75-Bn Organon & Co Acquisition Bid - outlookbusiness.com

Sun Pharma gets ratings boost from Moody's, S&P over ₹11.75-billion Organon & Co acquisition bid - BusinessLine

Sun Pharma gets ratings boost from Moody's, S&P over $11.75 bn Organon & Co acquisition bid - ET Manufacturing

Sun Pharma gets ratings boost from Moody's, S&P over USD 11.75-bn Organon & Co acquisition bid - The Economic Times

Sun Pharma Gets Ratings Boost After Organon Acquisition Bid - Rediff MoneyWiz

Organon & Co stock hits 52-week high at $13.78 By Investing.com - Investing.com Nigeria

Organon & Co stock hits 52-week high at $13.78 - Investing.com India

Organon earnings up next: Can drugmaker rebound after Q1 miss? - Investing.com

Organon (OGN) Move: Ends Up by 0.07% at $13.74 on the Day; Technical Setup: the $13.05 to $14.43 Range Remains in FocusBox Spread - Vinanet

Sun Pharma completes $11.75bn financing syndication for Organon acquisition - Generics and Biosimilars Initiative

Organon (OGN) Trading: Ends Up by 0.37% at $13.73 at the Close; Next Session: the Supplied Trading Band Runs From $13.04 to $14.42 under the Current SnapshotOvernight Profile - Vinanet

Organon & Co stock hits 52-week high at 13.73 USD - Investing.com

Organon & Co. (NYSE:OGN) Reaches New 12-Month HighStill a Buy? - MarketBeat

OGN Stock Set For Blastoff? Sun Pharma Offers 24% Premium In All-Cash Buyout Deal - Stocktwits

Orographic Financial Advisors, LLC's Organon & Co(OGN) Holding History - GuruFocus

how InvestingPro’s Fair Value spotted Organon’s 69% gain potential By Investing.com - Investing.com South Africa

Organon (OGN): Pentwater Capital discloses 18.1M-share, 6.9% ownership stake - Stock Titan

Kevin Hern sells stocks in Organon & Co. and Versant Media Group - Investing.com Nigeria

Kevin Hern sells stocks in Organon & Co. and Versant Media Group By Investing.com - Investing.com Australia

This House of Representative Just Sold Up To $30K In Organon Stock - Benzinga

Organon & Co To Go Ex-Dividend On August 14th, 2026 With 0.02 USD Dividend Per Share - 富途牛牛

Organon & Co. (NYSE:OGN) Reaches New 1-Year HighShould You Buy? - MarketBeat

Sei Investments Co. Has $1.14 Million Holdings in Organon & Co. $OGN - MarketBeat

Quantinno Capital Management LP Sells 98,466 Shares of Organon & Co. $OGN - MarketBeat

Organon & Co. R&D Chief Juan Camilo Arjona Ferreira Completes Final RSU Vesting and Tax Withholding - Kalkine Media

Organon & Co. (OGN) CMO exercises 11,519 RSUs and withholds 4,134 shares for costs - Stock Titan

Organon & Co. $OGN Shares Purchased by California State Teachers Retirement System - MarketBeat

Trading the Move, Not the Narrative: (OGN) Edition - Stock Traders Daily

Rep. Kevin Hern Sells Shares of Organon & Co. (NYSE:OGN) - MarketBeat

Organon opens enrollment for Miudella IUD safety program By Investing.com - Investing.com Australia

Organon opens enrollment for Miudella IUD safety program - Investing.com

Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability - Business Wire

Organon earnings in focus as Sun Pharma deal looms By Investing.com - Investing.com UK

Organon earnings in focus as Sun Pharma deal looms - Investing.com

Organon & Co stock hits 52-week high at 13.61 USD - Investing.com Australia

Organon & Co. (NYSE:OGN) Reaches New 52-Week HighShould You Buy? - MarketBeat

Organon & Co. $OGN Shares Sold by Dimensional Fund Advisors LP - MarketBeat

Organon & Co. (OGN) Stock Forecasts - Yahoo Finance

OGN (NYSE: OGN) details 14,761-share Rule 144 common stock sale plan - Stock Titan

Finanzdaten der Organon Co-Aktie (OGN)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie OGN